305 related articles for article (PubMed ID: 29587278)
21. Testicular seminoma: Are clinical features and treatment outcomes any different in India?
Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
[TBL] [Abstract][Full Text] [Related]
22. [Radiotherapy of testicular seminoma: changes over the past 10 years].
Mirimanoff RO
Cancer Radiother; 2003 Nov; 7 Suppl 1():70s-77s. PubMed ID: 15124547
[TBL] [Abstract][Full Text] [Related]
23. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
25. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.
Dieckmann KP; Matthies C; Kliesch S
J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458
[No Abstract] [Full Text] [Related]
26. [Radiotherapy in stage I testicular seminoma: retrospective study and review of literature].
Bauduceau O; Souleau B; Le-Moulec S; Houlgatte A; Bernard O
Cancer Radiother; 2003 Dec; 7(6):386-94. PubMed ID: 14725912
[TBL] [Abstract][Full Text] [Related]
27. Myths and facts on adjuvant carboplatin for stage I seminoma.
Aparicio J; Germà JR
J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
[No Abstract] [Full Text] [Related]
28. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
30. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
31. Intertubular growth in pure seminomas: associations with poor prognostic parameters.
Browne TJ; Richie JP; Gilligan TD; Rubin MA
Hum Pathol; 2005 Jun; 36(6):640-5. PubMed ID: 16021570
[TBL] [Abstract][Full Text] [Related]
32. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
Koutsoukos K; Tzannis K; Christodoulou C; Karavasilis V; Bakoyiannis C; Makatsoris T; Papandreou CN; Pectasides D; Dimopoulos MA; Bamias A
World J Urol; 2016 Jun; 34(6):853-7. PubMed ID: 26410826
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
Choo R; Thomas G; Woo T; Lee D; Kong B; Iscoe N; Danjoux C; Klotz L; Morton G; Chander S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):736-40. PubMed ID: 15708251
[TBL] [Abstract][Full Text] [Related]
34. Carboplatin in clinical stage I seminoma: too much and too little at the same time.
Bosl GJ; Patil S
J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532
[No Abstract] [Full Text] [Related]
35. [Infertility and testicular seminoma].
Lakmichi MA; Niang L; Tligui M; Traxer O; Cussenot O; Gattegno B; Thibault P; Sebe P
Presse Med; 2007 Dec; 36(12 Pt 1):1753-5. PubMed ID: 17560758
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant carboplatin treatment for seminoma clinical stage I.
Dieckmann KP; Krain J; Küster J; Brüggeboes B
J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595
[TBL] [Abstract][Full Text] [Related]
37. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
[TBL] [Abstract][Full Text] [Related]
38. Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
Tyrrell HEJ; Church DN; Joseph J; Traill ZC; Sullivan ME; Tuthill MH; Verrill CL; Pintus EP; Dallas NL; Rogers PB; Redgwell J; Protheroe AS
Clin Genitourin Cancer; 2018 Jun; 16(3):240-244. PubMed ID: 29336917
[TBL] [Abstract][Full Text] [Related]
39. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]